Citadel Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,900
Closed -$13.9K 15998
2022
Q4
$13.9K Buy
+1,900
New +$13.4K ﹤0.01% 13420

Other funds holding AMYT

Citadel Advisors's AMYT Position: Q1 2023 in Review

Citadel Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 41,280 shares — an estimated $301K sold.

Citadel Advisors first reported a position in AMYT in Q2 2021 and held it in 7 quarters. The position peaked at $640K in Q2 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Citadel Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 41,280 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $301K.
  • Citadel Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 7 quarters.
  • Citadel Advisors's Amryt Pharma plc American Depositary Shares position peaked at $640K in Q2 2022.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.